### Latent variables (gene modules) information

#### LV603

<!-- LV603:multiplier_pathways:start -->
| Pathway                             | AUC   | FDR      |
|:------------------------------------|:------|:---------|
| IRIS Neutrophil-Resting             | 0.91  | 4.51e-35 |
| SVM Neutrophils                     | 0.98  | 1.43e-09 |
| PID IL8CXCR2 PATHWAY                | 0.81  | 7.04e-03 |
| SIG PIP3 SIGNALING IN B LYMPHOCYTES | 0.77  | 1.95e-02 |

Table: Pathways aligned to LV603 from the MultiPLIER models. {#tbl:sup:multiplier_pathways:lv603}
<!-- LV603:multiplier_pathways:end -->

<!-- LV603:phenomexcan_traits_assocs:start -->
| Trait description                         | Sample size   | Cases   | FDR            |
|:------------------------------------------|:--------------|:--------|:---------------|
| Basophill percentage                      | 349,861       |         | 1.19e&#8209;10 |
| Basophill count                           | 349,856       |         | 1.89e&#8209;05 |
| Treatment/medication code: ispaghula husk | 361,141       | 327     | 1.36e&#8209;02 |

Table: Significant trait associations of LV603 in PhenomeXcan. {#tbl:sup:phenomexcan_assocs:lv603}
<!-- LV603:phenomexcan_traits_assocs:end -->

<!-- LV603:emerge_traits_assocs:start -->
| Phecode                     | Trait description   | Sample size   | Cases   | FDR   |
|:----------------------------|:--------------------|:--------------|:--------|:------|
| No significant associations |                     |               |         |       |

Table: Significant trait associations of LV603 in eMERGE. {#tbl:sup:emerge_assocs:lv603}
<!-- LV603:emerge_traits_assocs:end -->
